©The Author(s) 2026.
World J Clin Oncol. Jan 24, 2026; 17(1): 113463
Published online Jan 24, 2026. doi: 10.5306/wjco.v17.i1.113463
Published online Jan 24, 2026. doi: 10.5306/wjco.v17.i1.113463
Table 2 Patients’ perception of gastric cancer risk with proton pump inhibitor
| PPI type | Risk perceived (%) | n |
| Dexlansoprazole | 18.9 | 14/74 |
| Esomeprazole | 22.8 | 164/719 |
| Lansoprazole | 24.1 | 172/715 |
| Omeprazole | 24.0 | 198/823 |
| Pantoprazole | 26.5 | 177/669 |
- Citation: Sawaied IO, Samson AO, Golan E. Patients’ perception of proton pump inhibitors use and their risks. World J Clin Oncol 2026; 17(1): 113463
- URL: https://www.wjgnet.com/2218-4333/full/v17/i1/113463.htm
- DOI: https://dx.doi.org/10.5306/wjco.v17.i1.113463